DexCom Inc (DXCM) stock
DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3030% below fair value
$82.52+0.48 (+0.59%)
Close on Nov 18, 2026Market cap $30.78BP/E 32.5Yield –
DexCom operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
DexCom's operating cash flow for the twelve months ending Sep 30, 2026 was $1.41B, down 2.3% year over year. For fiscal 2025 it was $1.44B, up 45.6% from the year before. Over ten years it grew 40.2% a year on average. The highest annual figure on record is $1.44B in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.44B | +45.6% |
| FY2024 | Dec 31, 2024 | $989.50M | +32.2% |
| FY2023 | Dec 31, 2023 | $748.50M | +11.8% |
| FY2022 | Dec 31, 2022 | $669.50M | +51.3% |
| FY2021 | Dec 31, 2021 | $442.50M | -7.0% |
| FY2020 | Dec 31, 2020 | $475.60M | +51.2% |
| FY2019 | Dec 31, 2019 | $314.50M | +155.3% |
| FY2018 | Dec 31, 2018 | $123.20M | +33.9% |
| FY2017 | Dec 31, 2017 | $92.00M | +63.7% |
| FY2016 | Dec 31, 2016 | $56.20M | +14.7% |
| FY2015 | Dec 31, 2015 | $49.00M | +107.6% |
| FY2014 | Dec 31, 2014 | $23.60M | +883.3% |
| FY2013 | Dec 31, 2013 | $2.40M | – |
| FY2012 | Dec 31, 2012 | -$33.10M | – |
| FY2011 | Dec 31, 2011 | -$30.10M | – |
| FY2010 | Dec 31, 2010 | -$42.70M | – |
| FY2009 | Dec 31, 2009 | -$39.39M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $325.60M | -50.7% |
| Q2 FY2026 | Jun 30, 2026 | $269.20M | -11.2% |
| Q1 FY2026 | Mar 31, 2026 | $525.60M | +186.0% |
| Q4 FY2025 | Dec 31, 2025 | $294.00M | -2.5% |
| Q3 FY2025 | Sep 30, 2025 | $659.90M | +230.8% |
| Q2 FY2025 | Jun 30, 2025 | $303.00M | +8.4% |
| Q1 FY2025 | Mar 31, 2025 | $183.80M | -12.1% |
| Q4 FY2024 | Dec 31, 2024 | $301.40M | +125.6% |
| Q3 FY2024 | Sep 30, 2024 | $199.50M | -25.9% |
| Q2 FY2024 | Jun 30, 2024 | $279.40M | +46.8% |
| Q1 FY2024 | Mar 31, 2024 | $209.20M | +34.6% |
| Q4 FY2023 | Dec 31, 2023 | $133.60M | +0.8% |
| Q3 FY2023 | Sep 30, 2023 | $269.20M | -8.2% |
| Q2 FY2023 | Jun 30, 2023 | $190.30M | +10.1% |
| Q1 FY2023 | Mar 31, 2023 | $155.40M | +118.9% |
| Q4 FY2022 | Dec 31, 2022 | $132.50M | +25.2% |
| Q3 FY2022 | Sep 30, 2022 | $293.20M | +18.6% |
| Q2 FY2022 | Jun 30, 2022 | $172.80M | +180.5% |
| Q1 FY2022 | Mar 31, 2022 | $71.00M | +155.4% |
| Q4 FY2021 | Dec 31, 2021 | $105.80M | -38.5% |
| Q3 FY2021 | Sep 30, 2021 | $247.30M | +67.5% |
| Q2 FY2021 | Jun 30, 2021 | $61.60M | -60.0% |
| Q1 FY2021 | Mar 31, 2021 | $27.80M | +1363.2% |
| Q4 FY2020 | Dec 31, 2020 | $172.00M | +19.7% |
| Q3 FY2020 | Sep 30, 2020 | $147.60M | +56.2% |
| Q2 FY2020 | Jun 30, 2020 | $154.10M | +138.9% |
| Q1 FY2020 | Mar 31, 2020 | $1.90M | -83.9% |
| Q4 FY2019 | Dec 31, 2019 | $143.70M | +326.4% |
| Q3 FY2019 | Sep 30, 2019 | $94.50M | +66.4% |
| Q2 FY2019 | Jun 30, 2019 | $64.50M | +55.8% |
| Q1 FY2019 | Mar 31, 2019 | $11.80M | – |
| Q4 FY2018 | Dec 31, 2018 | $33.70M | -18.2% |
| Q3 FY2018 | Sep 30, 2018 | $56.80M | +56.9% |
| Q2 FY2018 | Jun 30, 2018 | $41.40M | +189.5% |
| Q1 FY2018 | Mar 31, 2018 | -$8.70M | -3000.0% |
| Q4 FY2017 | Dec 31, 2017 | $41.20M | +209.8% |
| Q3 FY2017 | Sep 30, 2017 | $36.20M | – |
| Q2 FY2017 | Jun 30, 2017 | $14.30M | – |
| Q1 FY2017 | Mar 31, 2017 | $300.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $13.30M | – |
See a number that looks wrong?